XTransfer
  • Products & Services
  • About Us
  • Help & Support
English
Create account

Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)

HS Code: 3004909093

SECTION 6

PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES

CHAPTER 30

Pharmaceutical products

HEADING 3004

Medicaments（excluding goods of heading No.30.02

HS Code Structure Breakdown

LevelCodeDescription
Section6PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
Chapter30Pharmaceutical products
Heading3004Medicaments（excluding goods of heading No.30.02
Subheading300490Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)
Commodity3004909093Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)
Advertisement banner

Pay and get paid in local currency. Save up to 80% on your currency exchanges.

Get it for free now

HS Code 3004909093 for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)

Product Wiki

Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.

Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs), with its export volume maintaining a high level over the long term.

Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs).

With technological advancements and the diversification of market demands, the scope of application for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) continues to expand, driving the development of related industries.

Currently, the global supply-demand balance of Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.

Partner

OCBC
DBS
BANK OF CHINA

Our licenses

China

China

HK MSO License

HK MSO License

Singapore

Singapore

UK API License

UK API License

Netherlands

Netherlands

US MSB

US MSB

CA MSB

CA MSB

AU RSP

AU RSP

HS Code FAQ

What is the HS code for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)? Which HS classification does it belong to?

The HS code for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) is 3004909093. This product is classified under: Section 6, Chapter 30 (if applicable, otherwise not shown), Heading 3004 (if applicable, otherwise not shown). This code is used in international trade for the standardized classification and customs declaration of Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs).

What are the import VAT rate and export tax rebate rate for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)?

The import VAT rate and export tax rebate rate for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) depend on its specific HS Code, product category, and the latest customs tariff policies. In general, import VAT rates may fall under different brackets such as 13% or 9%, while export tax rebate rates may vary between 0%, 9%, and 13%. Different products are subject to different tax regulations and rebate policies. Please refer to the latest information released by customs and tax authorities for the most accurate rates.

Is the HS code for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) the same across different countries?

The HS code for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) under the internationally standardized HS coding system is 3004909093, but some countries may use different suffix extensions. It is recommended to confirm based on the customs regulations of the destination country.

How can I confirm whether Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) corresponds to the correct HS code?

You can determine this by checking the function, material, and usage of Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs), and verifying whether the corresponding HS code matches the actual classification rules. If necessary, official classification guidelines or historical declaration cases can also be referenced for validation.

How are the taxes and duties for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) calculated?

The taxes and duties for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) usually consist of customs duties, value-added tax , and other additional charges. The exact amount depends on the declared value and the import policies of the destination country.

What happens if the HS code 3004909093 for Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) is declared as a different HS code?

If Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) (HS Code: 3004909093) is declared incorrectly, it may result in customs clearance delays, tax adjustments, or compliance risks. It is recommended to correct the declaration as soon as possible or contact the customs clearance service provider for assistance. Platforms such as XTransfer can also provide declaration and risk control support to help reduce risks.